Suchergebnisse - "Kalkan, Hilal"

PubPharm (8)

1

Pharmacological evidences that the inhibitory effects of prostaglandin E2 are mediated by the EP2 and EP4 receptors in human neutrophils

enthalten in: Journal of leukocyte biology | 2024

von Lavoie, J. | Simard, M. | Kalkan, H. | +6

2

Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin

enthalten in: Cell death & disease | 2023

von Kalkan, H. | Panza, E. | Pagano, E. | +7

3

Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy

enthalten in: EMBO molecular medicine | 2023

von Kalkan, H. | Pagano, E. | Paris, D. | +12

CommentIn: EMBO Mol Med. 2023 Mar 8;15(3):e17324. - PMID 36843560

4

Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy

enthalten in: EMBO Molecular Medicine | 2023

von Kalkan, H. | Pagano, E. | Paris, D. | +12

5

The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity

enthalten in: Frontiers in aging neuroscience | 2022

von Lauritano, A. | Cipollone, I. | Verde, R. | +5

6

Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets

enthalten in: Biochemical pharmacology | 2020

von Fellous, T. | De Maio, F. | Kalkan, H. | +6

7

Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma

enthalten in: Leukemia | 2019

von Sasi, B. | Martines, C. | Xerxa, E. | +15

8

Synthesis and spectroscopic properties of β-meso directly linked porphyrin-corrole hybrid compounds

enthalten in: Beilstein journal of organic chemistry | 2018

von Temelli, B. | Kalkan, H.

1
[1]